Effective Use of Angiotensin II in Coronavirus Disease 19-Associated Mixed Shock State: A Case Report.
A A Pract
; 14(6): e01221, 2020 Apr.
Article
in English
| MEDLINE | ID: covidwho-325939
ABSTRACT
The rapid spread of Coronavirus Disease 2019 (COVID-19) has sparked a search for effective therapies. The discovery that the virus binds the angiotensin-converting enzyme 2 (ACE2) receptor has led to investigation of the renin-angiotensin system for possible therapeutic targets. We present a case of an elderly woman with multiple comorbidities who developed severe acute respiratory distress syndrome (ARDS), a cardiomyopathy, and vasodilatory shock secondary to COVID-19 and was treated with exogenous angiotensin II. She rapidly demonstrated significant hemodynamic improvement without noted adverse effects. Thus, we propose further investigation into possible benefits of angiotensin II in shock secondary to COVID-19.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Shock
/
Vasoconstrictor Agents
/
Angiotensin II
/
Coronavirus Infections
/
Betacoronavirus
Type of study:
Case report
/
Experimental Studies
Topics:
Long Covid
Limits:
Female
/
Humans
Language:
English
Journal:
A A Pract
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS